Dr. Gary Gibson Featured on Wall Street Journal Live

Published August 6, 2015

Gary Gibson, Ph.D., Director of the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration at the Burke Medical Research Institute was featured on Wall Street Journal Live on Tuesday.

On the program, Dr. Gibson discussed a clinical trial currently being conducted at BMRI for people with mild Alzheimer’s disease or mild cognitive impairment. The study aims to determine if increasing brain thiamine through the use of the drug benfotiamine can help slow cognitive decline.

The trial is being funded by the National Institutes of Health and the Alzheimer’s Drug Discovery Foundation and is currently recruiting participants. Additional investigators on the study include Barry D.  Jordan, M.D., MPHPasquale Fonzetti M.D., Ph.D., Rosanna Cirio, BS, MS  and Jessica Franchino-Elder Ph.D. If you think you or your loved one may qualify for the study, click here.

To view the Wall Street Journal Live segment, click here. Visit to learn about this study and other clinical trials being conducted at Burke.

Want to be the first to know when Burke is featured in the news? Follow us on Facebook and Twitter for current updates and the latest happenings, including events, behind-the-scenes photos and more! 

Subscribe to Burke's Newsletter

Keep up with the latest news about Burke by signing up for our newsletter. 

Burke Rehab Hospital Fact Sheets

Latest Tweet